A. T. Dinh-Xuan (Paris, France), H. Mal (Paris, France)
Changes in pulmonary capillary blood volume associated with pulmonary embolism
P. L. Piirilä, M. Laiho, M. Graner, P. Mustonen, V. P. Harjola, A. R. A. Sovijärvi (Helsinki, Finland)
|  |
Fibrinolysis with tenecteplase in the management of massive pulmonary embolism
E. Fernandez, P. Lopez, M. Ramón, G. Juan, R. Navarro, F. Sanz, T. Lloret (Valencia, Spain)
| |
A structured clinical model for predicting the probability of pulmonary embolism
D. S. Djordjevic Radojkovic, R. Jankovic, S. Apostolovic, M. Zivkovic (Nis, Serbia & Montenegro)
| |
Results of a dedicated service for pulmonary embolism (PE): 1 year follow up
C. Ribas, F. Mannucci, G. Palmiero, M. Gherardi, G. Bardi, N. Carpenè, M. Digiorgio, A. Innocenti, A. Palla (Pisa, Italy)
| |
Angiotensin-converting enzyme genotype modulates pulmonary artery pressure in COPD
P. Joppa, R. Tkacova, B. Stancak, J. Salagovic, A. Trejbalova (Kosice, Slovakia)
| |
The evaluation of airways mucosa vascular endothelial dysfunction
M. A. Menshoutina, E. J. Vasina, M. A. Ryabova, V. I. Trofimov, N. N. Petrishchev (St Petersburg, Russia)
| |
L-arginine plasma levels correlate with severity of primary pulmonary hypertension
M. Halank, J. Beyer, C. Rubens, C. Marx, S. Usicenko, R. Ewert, G. Hoeffken (Dresden, Berlin, Greifswald, Germany)
| |
Serum levels of circulating FAS/APO-1 in patients with isolated left- and right ventricular dysfunction
Y. Staudt, R. Ewert, S. B. Felix, A. Staudt, S. Lodziewski (Greifswald, Germany)
| |
Hypoxia-induced proliferation of human pulmonary artery smooth muscle cells: possible mechanisms
C. Lord, M. Harnett, M. MacLean (Glasgow, United Kingdom)
| |
The effect of montelukast on the monocrotaline induced pulmonary disease in the wistar rat
S. N. Bogdan, M. Branaru, M. F. Draghici, P. Galbenu, M. A. Bogdan (Bucharest, Romania)
| |
Pulmonary arterial responses to 5-HT in a novel mouse model of fPAH
I. Morecroft, J. Sheward, A. Harmar, M. R. MacLean (Glasgow, Edinburgh, United Kingdom)
| |
Sustained PAP-reduction and tissue cGMP-restoration without systemic NO-generation by aerosolized PAPA-NONOate in an isolated lung model of acute lung injury
H. Wahn, F. Finter, H. Kaufmann (Wangen im Allgäu, Würzburg, Germany)
| |
Oleic acid induces alveolar oedema by direct inhibition of the Na+,K+-ATPase in an intact isolated lung model
I. Vadasz, H. A. Ghofrani, M. G. Kohstall, R. E. Morty, F. Grimminger, W. Seeger (Giessen, Germany)
| |
Role of tumor necrosis factor alpha in hepatopulmonary syndrome
L. Saval, S. Eddahibi, M. Mazmanian, D. Lebrec, P. Herve (Le Plessis Robinson, Creteil, Clichy, France)
| |
Effects of nitric oxide synthesis inhibition on pulmonary gas exchange in hepatopulmonary syndrome
F. P. Gómez, G. P. Martínez, E. Polverino, J. A. Barberà, J. Roca, R. Rodriguez-Roisin (Barcelona, Spain)
| |
Response to maximal cardiopulmonary exercise testing in patients with hepatopulmonary syndrome
F. Martin- Vivaldi, E. Fernandez, B. Hortal, M. Ortega, J. M. Diez, C. Martin, M. C. Contreras, M. Guillamon, G. Jimenez, B. Alcazar (Granada, Spain)
| |
The prevalence of hepatopulmonary syndrome in 445 patients, candidates to hepatic transplant
E. Garcia, C. A. Marroni (Porto Alegre, Brazil)
| |
Shunt fractions and arterial oxygenation in liver transplantation candidates with diferent levels of intrapulmonary vascular dilatations by contrast-enhanced echocardiography
M. A. P. Ferreira, M. M. Knorst, S. S. Menna-Barreto, A. F. Pinotti, M. R. Álvares-da-Silva (Porto Alegre, Brazil)
| |
Lung gas exchange during exercise in a patient with hepatopulmonary syndrome (HPS): effect of oxygen breathing
G. Valli, A. Fedeli, P. Paoletti, R. Antonucci, R. DeMarco, S. Ginanni Corradini, P. Onorati, P. Palange (Rome, Italy)
| |